Cited by 64Bipolar Disorder and TreatmentTreatment of Major DepressionPsychological Treatments and Disorders

Morbidity in depressive disorders

Open access
Baldessarini, Ross J., Forte, Alberto, Selle, Valerio, Sim, Kang, Tondo, Leonardo, Undurraga, Juan, Vázquez, Gustavo H.·2017·Psychotherapy and Psychosomatics

Abstract

Conceptualizations about Mood DisordersKraepelin's introduction of the broad category of manic-depressive illness in the mid 1890s was followed by efforts to differentiate and define limits of potentially separable syndromes included in the original concept [2,3] .These efforts led to differentiation of BD and unipolar

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000448661

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The diagnosis of major depressive disorder is likely causally heterogeneous.

    “Further, the diagnosis of major depressive disorder (MDD) is likely causally heterogeneous.”

    From Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis (2018) · cites this paper as Baldessarini et al., 2017

    The paper’s Abstract says the MDD diagnosis grouped a broad range of depressive conditions and describes the MDD concept as heterogeneous. It does not specify that this heterogeneity is causal, so it supports the broader point but not that qualifier. The indexed passage has no page number. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 93 references couldn’t be matched to a known paper.

Research works printed but not linked: 19

  1. [2]2. Goodwin FK, Jamison KR: Manic Depressive Illness, ed 2. New York, Oxford University Press, 2007.
  2. [3]3. Baldessarini RJ, Pérez J, Salvatore P, Trede K, Maggini C: History of bipolar manic-depres- sive disorder; in Yildiz A, Nemeroff C, Ruiz P (eds): The Bipolar Book: History, Neurobiol- ogy, and Treatment. New York: Oxford Uni- versity Press, 2015, pp 3-20.
  3. [4]4. Strakowski SM, Nelson EB: Major Depressive Disorder. New York: Oxford University Press, 2015.
  4. [8]8. Spiessl H, Hübner-Liebermann B, Cording C: Differences between unipolar and bipolar af- fective disorders. Review and results from a clinical population (in German). Fortschr Neurol Psychiatr 2002; 70: 403-409.
  5. [14]14. Weibel S, Bertschy G: Mixed depression and DSM-5: a critical review (in French). En- cephale 2016; 42: 90-98.
  6. [20]20. Tondo L, Baldessarini RJ: Suicide in bipolar disorder; in Yildiz A, Nemeroff C, Ruiz P (eds): The Bipolar Book: History, Neurobiol- ogy, and Treatment. New York, Oxford Uni- versity Press, 2015, pp 509-528.
  7. [22]22. Undurraga J, Baldessarini RJ: A 30-year meta- analytic review of antidepressant efficacy in acute major depression. Neuropsychophar- macology 2012; 37: 851-864.
  8. [32]32. Vázquez GH, Tondo L, Undurraga J, Zaratie- gui R, Baldessarini RJ: Pharmacological treat- ment for bipolar depression. Adv Psychiatr Treat 2014; 20: 193-201.
  9. [35]35. Ghaemi SN, Wingo AP, Filkowski MA, Baldessarini RJ: Effectiveness of long-term antidepressant treatment in bipolar disorder: a meta-analysis. Acta Psychiatr Scand 2008; 118: 347-356.
  10. [43]43. Perugi G, Angst J, Azorin JM, Bowden CL, Mosolov S, Reis J, Vieta E, Young AH: Bridge- II-Mix study. J Clin Psychiatry 2015; 76: 351- 358.
  11. [47]47. Tondo L, Hennen J, Baldessarini RJ: Meta- analysis of treatment responses of rapid-cy- cling and non-rapid-cycling bipolar disorder patients. Acta Psychiatr Scand 2003; 104: 4-14.
  12. [56]56. Serna MC, Real J, Cruz I, Galván L, Martin E: Monitoring patients on chronic treatment with antidepressants between 2003 and 2011: analysis of factors associated with compli- ance. BMC Public Health 2015; 15: 1184-1193.
  13. [57]57. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J: Prescribing patterns of psychotropic medicines in the United States for patients diagnosed with bipolar disorders. Psychiatr Serv 2007; 58: 85-91.
  14. [60]60. Zhou X, Ravindran AV, Qin B, Del Giovane C, Li Q, Bauer M, Liu Y, Fang Y, da Silva T, Zhang Y, Fang L, Wang X, Xie P: Comparative effi- cacy, acceptability, and tolerability of aug- mentation agents in treatment-resistant de- pression: systematic review and network me- ta-analysis. J Clin Psychiatry 2015; 76:e48-e98.
  15. [63]63. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ: Risk of discontin- uing lithium maintenance in pregnant vs. nonpregnant women with bipolar disorders. Am J Psychiatry 2000; 157: 179-184.
  16. [64]64. Baldessarini RJ, Tondo L, Ghiani C, Lepri B: Discontinuation rate vs. recurrence risk fol- lowing long-term antidepressant treatment in major depressive disorder patients. Am J Psy- chiatry 2010; 167: 934-941.
  17. [65]65. the difference between dependence and with- drawal reactions? A comparison of benzodi- azepines and selective serotonin re-uptake in- hibitors. Addiction 2012; 107: 900-908.
  18. [72]72. Loebel A, Xu J, Hsu J, Cucchiaro J, Pikalov A: Development of lurasidone for bipolar de- pression. Ann NY Acad Sci 2015; 1358: 95- 104.
  19. [92]92. Salcedo S, Gold AK, Sheikh S, Marcus PH, Nierenberg AA, Deckersbach T, Sylvia LG: Empirically supported psychosocial interven- tions for bipolar disorder: current state of re- search. J Affect Disord 2016; 201: 203-214.

Cited by

Sorted by citations

Authors
Baldessarini, R. J., Forte, A., Selle, V., Sim, K., Tondo, L., Undurraga, J., & Vázquez, G. H.
Affiliations
  • McLean Hospital (US)
  • Harvard University (US)
  • Universidad del Desarrollo (CL)
  • Queen's University (CA)
Venue
Psychotherapy and Psychosomatics
Publisher
S. Karger AG
Published
2017
Volume
86
Issue
2
Pages
65-72
ISSN
  • 0033-3190 (ISSN-L)
  • 1423-0348
OpenAlex
W2588483919
Cited by
63
References
93
Citations by year
2026: 2 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 10 · 2021: 5 · 2020: 6 · 2019: 13 · 2018: 9 · 2017: 2
FWCI
6.74
Type
journal article
Language
en
Open access
Locations
  • Psychotherapy and Psychosomatics (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Funders
  • Aretaeus Foundation of Rome
  • Bruce J. Anderson Foundation
  • National Commission for Science and Technology
  • Clínica Alemana de Santiago
  • Comisión Nacional de Investigación Científica y Tecnológica (ACT1414)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
depressive disorders, morbidity, mood disorders, bipolar disorder, major depressive disorder, history of psychiatry
MeSH terms
Antidepressive Agents, Depressive Disorder, Humans, Morbidity, Risk Factors, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review